Lung transplantation in idiopathic pulmonary fibrosis-Reference-Cited by-同舟云学术

Lung transplantation in idiopathic pulmonary fibrosis

Published:2018-04-20 Issue:5 Volume:12 Page:375-385
ISSN:1747-6348
Container-title:Expert Review of Respiratory Medicine
language:en
Short-container-title:Expert Review of Respiratory Medicine

Author:

Kumar Anupam¹,Kapnadak Siddhartha G.²,Girgis Reda E.³,Raghu Ganesh⁴

Affiliation:

1. Division of Pulmonary & Critical Care Medicine, Richard DeVos Heart & Lung Transplant Program, Spectrum Health-Michigan State University College of Human Medicine, Grand Rapids, MI, USA

2. Division of Pulmonary and Critical Care Medicine, University of Washington Medical Center, Seattle, WA, USA

3. Medical Director, Lung Transplantation and Pulmonary Hypertension, Richard DeVos Heart & Lung Transplant Program, Spectrum Health- Michigan State University College of Human Medicine, Grand Rapids, MI, USA

4. Center for Interstitial Lung Diseases, Division of Pulmonary & Critical Care Medicine, University of Washington Medical Center, Seattle, WA, USA

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/17476348.2018.1462704

Reference70 articles.

1. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline

2. Idiopathic Pulmonary Fibrosis

3. Impact of U.S. Lung Allocation Score on Survival After Lung Transplantation

4. Lung

5. The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Lung and Heart–Lung Transplant Report—2016; Focus Theme: Primary Diagnostic Indications for Transplant

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring ABHD5 as a Lipid-Related Biomarker in Idiopathic Pulmonary Fibrosis: Integrating Machine Learning, Bioinformatics, and In Vitro Experiments;Inflammation;2024-07-24

2. Novel therapeutic strategies and drugs for idiopathic pulmonary fibrosis;Archiv der Pharmazie;2024-07-03

3. Targeting iron-metabolism:a potential therapeutic strategy for pulmonary fibrosis;Biomedicine & Pharmacotherapy;2024-03

4. Circular RNAs and their roles in idiopathic pulmonary fibrosis;Respiratory Research;2024-02-06

5. Pyroptosis-related signatures predict immune characteristics and prognosis in IPF;Heliyon;2024-01